Selection criteria for drug‐like compounds

Medicinal Research Reviews - Tập 23 Số 3 - Trang 302-321 - 2003
Ingo Muegge1
1Bayer Research Center, 400 Morgan Lane, West Haven, Connecticut 06516

Tóm tắt

AbstractThe fast identification of quality lead compounds in the pharmaceutical industry through a combination of high throughput synthesis and screening has become more challenging in recent years. Although the number of available compounds for high throughput screening (HTS) has dramatically increased, large‐scale random combinatorial libraries have contributed proportionally less to identify novel leads for drug discovery projects. Therefore, the concept of ‘drug‐likeness’ of compound selections has become a focus in recent years. In parallel, the low success rate of converting lead compounds into drugs often due to unfavorable pharmacokinetic parameters has sparked a renewed interest in understanding more clearly what makes a compound drug‐like. Various approaches have been devised to address the drug‐likeness of molecules employing retrospective analyses of known drug collections as well as attempting to capture ‘chemical wisdom’ in algorithms. For example, simple property counting schemes, machine learning methods, regression models, and clustering methods have been employed to distinguish between drugs and non‐drugs. Here we review computational techniques to address the drug‐likeness of compound selections and offer an outlook for the further development of the field. © 2003 Wiley Periodicals, Inc. Med Res Rev, 23, No. 3, 302‐321, 2003

Từ khóa


Tài liệu tham khảo

10.1021/cc9800024

10.1021/cc000096t

10.1016/S1056-8719(00)00107-6

10.1016/S1359-6446(99)01451-8

10.1016/S1367-5931(99)80058-1

10.1016/S0169-409X(02)00003-0

10.1021/cc990032m

10.1021/ci970429i

10.1007/BF03380186

10.1016/S1359-6446(97)01163-X

10.1021/jm00009a003

10.1002/(SICI)1097-0290(199824)61:1<61::AID-BIT11>3.0.CO;2-C

10.1016/S1093-3263(01)00127-9

10.1023/A:1015040217741

10.1021/jm000292e

10.1021/js9804011

10.1016/S0169-409X(96)00423-1

10.1002/9783527613083.ch2

Podlogar BL, 2001, Computational methods to estimate drug development parameters, Current Opinion in Drug Discovery & Development, 4, 102

10.2174/1386207013330896

10.1002/1521-3765(20020503)8:9<1976::AID-CHEM1976>3.0.CO;2-K

Comprehensive Medical Chemistry is available from MDL Information Systems Inc. San Leandro CA 94577 and contains drugs already on the market.

World Drug Index is available from Derwent Information London UK. Websitewww.derwent.com

MACCS‐II Drug Data Report is available from MDL Information Systems Inc. San Leandro CA 94577 and contains biologically active compounds in the early stages of drug development.

10.1023/A:1008130001697

The Available Chemicals Database (version 99.2) was provided by Mdl Information Systems Inc. 1999.

10.1021/cc9800071

10.1021/ci990423o

10.1016/S1359-6446(97)01083-0

National Toxicology Program.http://ntp‐server.nichs.nih.gov

RTECS C2(96‐4); National Institute for Occupational Safety and Health (NIOSH).1996. U.S. Department of Health and Human Services Washington D.C. URL:www.ccohs.ca

10.1016/0027-5107(94)90124-4

10.1016/0027-5107(94)90125-2

Lhasa Ltd. School of Chemistry University of Leeds Leeds UK. URL:www.chem.leeds.ac.uk/LUK/derek/index.html

10.1021/jm9602928

10.1021/jm9903996

10.1021/ci990039r

10.1016/S1093-3263(97)00009-0

10.1021/ci0100806

10.1021/jm015507e

Top 200 drugs URL:http://www.destinationrx.com/learningcenter/topdrugs.asp?sort=rank

10.1021/jm970666c

10.1021/jm9706776

10.1021/ci990266t

10.1021/ci00063a006

10.1021/ci0003810

10.1021/jm990017w

QuinlanJR C5.0 release 1.08a; Rule Quest Research Pty Ltd. St Ives NSW Australia. URL:http://www.rulequest.com

10.1002/9780470125793.ch9

QuinlanJR.C4.5 Programs for machine learning Morgan Kaufmann 1993.

10.1021/jm011027b

10.1021/ci000026

10.1080/10629360290014331

10.1021/ci950168h

SPECS/BioSPECS Database version 94.5. Brandon Associates Merrimack NH 03054.

10.1002/(SICI)1521-3773(19991216)38:24<3743::AID-ANIE3743>3.0.CO;2-U

10.1021/jm00378a021

Daylight Chemical Information Systems Inc. Mission Viejo CA. URL:www.daylight.com

10.1021/ci980332b

Zheng W, 2000, PICCOLO: A tool for combinatorial library design via multicriterion optimization, Pac Symp Biocomput, 588

10.1021/ci990261w

10.1002/(SICI)1521-3773(19990301)38:5<643::AID-ANIE643>3.0.CO;2-G

DNP: Dictionary of Natural Products on CD‐Rom (Chapman & Hall) 78318 structures (June1996).

BNPD: Bioactive natural product database Szenzor Management Consulting Company Budapest Hungary (by Berdy) 29432 entries of natural products with described biological activity (July1996).

Drugs in‐house database of compounds in development 14596 entries (July1996).

10.1021/ci9904259

10.1021/ci970431

SPRESI distributed by Daylight Chemical Information Systems Inc. Mission Viejo CA.

10.1016/S1093-3263(01)00103-6

Brunne RM, 2000, Handbook of combinatorial chemistry, 761

10.1021/jm020017n

10.1002/0471266949.bmc006

10.1016/S0960-894X(02)00244-5

Thông tin
Thông tin xuất bản

Medicinal Research Reviews

Tập 23 Số 3

302-321

Thông tin tác giả